Cross Country Healthcare (CCRN) Cash from Financing Activities (2010 - 2026)

Cross Country Healthcare has reported Cash from Financing Activities for 17 years, with the latest figure at -$6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 36.63% year-over-year to -$6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$14.7 million (up 58.97% YoY), and the FY2025 full-year result was -$13.0 million, up 72.24% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$6.5 million, up from -$6.5 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $31.3 million in Q1 2022, with the low at -$114.9 million in Q2 2023.
• Historically, Cash from Financing Activities has averaged -$22.1 million across 5 years, with a median of -$6.5 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 756.56% — and 2025, when it soared 99.95%.
• Cross Country Healthcare's Cash from Financing Activities stood at $6.1 million in 2022, then slumped by 205.61% to -$6.4 million in 2023, then jumped by 36.46% to -$4.1 million in 2024, then slumped by 59.9% to -$6.5 million in 2025, then climbed by 0.97% to -$6.5 million in 2026.
• The last three Cash from Financing Activities figures came in at -$6.5 million (Q1 2026), -$6.5 million (Q4 2025), and -$6000.0 (Q3 2025), per Business Quant data.